Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Target based chemotherapeutic advancement of ruthenium complexes
They can have more stamina and less downtime between events
Raza A, Galili N, Smith S, Godwin J, Lancet J, Melchert M et al
Importantly, 5FU-based combination treatment also shows an increase in mitochondrial mass (FOLFOX (5FU + 1 M oxaliplatin) or FOLFIRI (5FU + 5 nM SN38, active metabolite of irinotecan)) that we attribute to 5FU-imposed stress, given that single-agent oxaliplatin or SN38 do not promote the same degree of mitochondrial adaptation (Extended Data Fig
Always clean with an alcohol swab before withdrawing its contents
US$ 23.60
US$ 26.05
US$ 26.66
US$ 24.33
